News from members and partners
The College of American Pathologists (CAP) is a medical society serving more than 17,000 physician members and the laboratory community throughout the world. It is the world’s largest association composed exclusively of board-certified pathologists and is widely considered the leader in laboratory quality assurance. The College is an advocate for high-quality and cost-effective patient care. The CAP accredits more than 7,000 laboratories and provides proficiency testing programs to approximately 23,000 laboratories. Pathologists play an integral role in the primary health care team as the physicians who obtain and interpret data as the result of the examination of tissues, blood, and other body fluids for diagnosis and patient care. CAP members are involved in a broad range of disciplines, including surgical pathology, cytopathology, dermatopathology, neuropathology, forensic pathology, blood banking/ transfusion medicine, clinical chemistry, microbiology, immunopathology, hematology, genetics, and molecular pathology. Their expertise and impact in healthcare delivery enable accountable and personalized care as they provide the precision and expertise needed to accurately diagnose, treat, and monitor each patient’s progress and optimize care.
The CAP developed the Pathology and Laboratory Quality Center or “the Center” in 2010 to author practice guidelines and consensus statements. Focused on optimizing patient safety and outcomes, most topics originate with practicing pathologists who describe variance in approaches to care, test selection and diagnosis. Ideally, Center guidelines may offer reduction in risk to the patient, while making efficient use of resources for timely and accurate diagnosis. Many Center guidelines begin in traditional clinical settings where patients present with symptoms and healthcare providers order laboratory exams or collect specimens. The process often extends beyond the laboratory where molecular markers are increasingly used to guide therapy and fosters partnering with other pathology and clinical specialties on CAP guidelines.
For more information: www.cap.org
The Android version of SIGN’s app went onto Android Market on June 13th and downloads 10 days later were at 900. The app is not only downloaded in the UK but worldwide including USA, Brazil, Malaysia, Kuwait, Australia and India. Download of the Apple app are at 12,985.
Figures from Apple show 4,274 downloads on one day alone (June 21st). This is due to the presentation of the app on the BBC website, Good Morning Scotland and World Service Radio and the breakfast and afternoon editions of Reporting Scotland.
Access the BBC story on: http://www.bbc.co.uk/news/uk-scotland-glasgow-west-13847790
AGREE II Translations
AGREE II has already been translated into several languages and we have many more in progress (see below). We would like to express our sincere thanks and appreciation to all those who have worked so hard to make the translations a reality. New translations are continually being added, so check the website often (http://www.agreetrust.org/resource-centre/agree-ii-translations/).
List of Translations completed:
List of Translations in progress:
- Czech Slovakian
- Farsi (Persian)
- Portuguese (Portugal)
NEW on-line AGREE II Training Tools
The AGREE A3 Research Team has developed two new on-line training tools to facilitate the application of the AGREE II tool. The tools are posted on the AGREE Enterprise website and are ready for use! http://www.agreetrust.org/resource-centre/training/. The AGREE II Overview Tutorial provides a quick overview of the tool, while the AGREE II Overview Tutorial + Practice Exercise also includes a practice session with automatic feedback on the trainee’s practice ratings. Both tools were evaluated and the final publication of the study has been accepted and will be available soon.
NEW AGREE Study Underway
The AGREE A3 research team is currently undertaking a program of research to develop a tool kit to facilitate explicit, transparent, and considered judgments in the development of guideline recommendations by guideline development panels. AGREE II focuses on methodological issues relevant to practice guideline development and reporting but does not address “clinical relevance” of practice guideline recommendations, an important precursor to the uptake of the recommendations. Given that at present no tool or tool kit exists to adequately address this issue, the AGREE A3 research team will address this gap by providing guidance to inform the development, reporting and evaluation of this concept. For more information, please visit http://www.agreetrust.org/research-projects/current-research-projects/.
Did You Know...
The AGREE Enterprise website (www.agreetrust.org) has a specific section for users, where you can create your own account for free? Doing so allows you to not only appraise practice guidelines using the AGREE II, but also provides you with the opportunity to create your own library of appraisals and practice guidelines and to share them with others. A total of 649 users have established their own account since the September 2010 launch of the new website. We look forward to you joining us too! http://www.agreetrust.org/login/index.aspx?ref=%2fmod_product%2fagree%2fmyagree.aspx%3f
If you have any questions or would like to get in touch with us at the AGREE II Office, please contact us at firstname.lastname@example.org.